BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 14659004)

  • 1. Endophilins interact with Moloney murine leukemia virus Gag and modulate virion production.
    Wang MQ; Kim W; Gao G; Torrey TA; Morse HC; De Camilli P; Goff SP
    J Biol; 2003; 3(1):4. PubMed ID: 14659004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.
    Yuan B; Campbell S; Bacharach E; Rein A; Goff SP
    J Virol; 2000 Aug; 74(16):7250-60. PubMed ID: 10906179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects in virion production caused by mutations affecting the C-terminal portion of the Moloney murine leukemia virus capsid protein.
    Wang MQ; Goff SP
    J Virol; 2003 Mar; 77(5):3339-44. PubMed ID: 12584360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine infectious anemia virus utilizes host vesicular protein sorting machinery during particle release.
    Tanzi GO; Piefer AJ; Bates P
    J Virol; 2003 Aug; 77(15):8440-7. PubMed ID: 12857913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carboxy-terminal fragment of nucleolin interacts with the nucleocapsid domain of retroviral gag proteins and inhibits virion assembly.
    Bacharach E; Gonsky J; Alin K; Orlova M; Goff SP
    J Virol; 2000 Dec; 74(23):11027-39. PubMed ID: 11069998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late domain-independent rescue of a release-deficient Moloney murine leukemia virus by the ubiquitin ligase itch.
    Jadwin JA; Rudd V; Sette P; Challa S; Bouamr F
    J Virol; 2010 Jan; 84(2):704-15. PubMed ID: 19864377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-terminal portion of the Hrs protein interacts with Tsg101 and interferes with human immunodeficiency virus type 1 Gag particle production.
    Bouamr F; Houck-Loomis BR; De Los Santos M; Casaday RJ; Johnson MC; Goff SP
    J Virol; 2007 Mar; 81(6):2909-22. PubMed ID: 17182674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein.
    Fan H; Chute H; Chao E; Feuerman M
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5965-9. PubMed ID: 6310608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
    Cimarelli A; Luban J
    J Virol; 1999 Jul; 73(7):5388-401. PubMed ID: 10364286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport and assembly of gag proteins into Moloney murine leukemia virus.
    Hansen M; Jelinek L; Whiting S; Barklis E
    J Virol; 1990 Nov; 64(11):5306-16. PubMed ID: 1698996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus.
    Ott DE; Coren LV; Copeland TD; Kane BP; Johnson DG; Sowder RC; Yoshinaka Y; Oroszlan S; Arthur LO; Henderson LE
    J Virol; 1998 Apr; 72(4):2962-8. PubMed ID: 9525617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small loop in the capsid protein of Moloney murine leukemia virus controls assembly of spherical cores.
    Auerbach MR; Brown KR; Kaplan A; de Las Nueces D; Singh IR
    J Virol; 2006 Mar; 80(6):2884-93. PubMed ID: 16501097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virus-related virus replication through human APOBEC3-independent mechanisms.
    Nitta T; Lee S; Ha D; Arias M; Kozak CA; Fan H
    Retrovirology; 2012 Jul; 9():58. PubMed ID: 22828015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA sequences in the Moloney murine leukemia virus genome bound by the Gag precursor protein in the yeast three-hybrid system.
    Evans MJ; Bacharach E; Goff SP
    J Virol; 2004 Jul; 78(14):7677-84. PubMed ID: 15220442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of a Gag-nuclease fusion protein against retroviral infection in vivo.
    Schumann G; Hermankova M; Cannon K; Mankowski JL; Boeke JD
    J Virol; 2001 Aug; 75(15):7030-41. PubMed ID: 11435583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic assay for multimerization of retroviral gag polyproteins.
    Luban J; Alin KB; Bossolt KL; Humaran T; Goff SP
    J Virol; 1992 Aug; 66(8):5157-60. PubMed ID: 1629970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudotype-independent nonspecific uptake of gammaretroviral and lentiviral particles in human cells.
    Voelkel C; Galla M; Dannhauser PN; Maetzig T; Sodeik B; Schambach A; Baum C
    Hum Gene Ther; 2012 Mar; 23(3):274-86. PubMed ID: 22010882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation.
    Zhang Y; Barklis E
    J Virol; 1995 Sep; 69(9):5716-22. PubMed ID: 7637017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag.
    Nitta T; Tam R; Kim JW; Fan H
    mBio; 2011; 2(1):e00341-10. PubMed ID: 21343359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution mutations affecting a small region of the Moloney murine leukemia virus MA gag protein block assembly and release of virion particles.
    Granowitz C; Goff SP
    Virology; 1994 Nov; 205(1):336-44. PubMed ID: 7975229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.